The Decision Nobody Talks About
There are hundreds of guides telling you which supplements to start. There are almost none telling you how to decide when to stop.
Yet the stop decision is just as important as the start. Taking an ineffective supplement for months is a waste of money and a distortion of your data. Stopping one prematurely means you may never learn whether it would have helped. And continuing a supplement despite early side effects because you have already bought three months of supply is a trap more people fall into than would admit it.
A data-driven stopping framework turns this from a vague, nagging question into a clear decision with defined criteria.
Related: Our Experiment Builder can help you apply these ideas. For the complete picture, see our The Complete Guide to Supplement Tracking.
The Four Stopping Triggers
Trigger 1: No Measurable Improvement After an Adequate Trial Period
This is the most common reason to stop — and the most frequently misapplied, because "adequate" is doing a lot of work in that sentence.
An adequate trial period means you ran the experiment long enough for the compound to have a reasonable opportunity to produce an effect. That means:
- Fast-acting compounds (L-theanine, glycine): minimum 2 weeks of consistent use
- Medium-acting compounds (magnesium, ashwagandha, creatine): minimum 4–6 weeks
- Slow-acting compounds (vitamin D, lion's mane, collagen): minimum 8–12 weeks
If you have completed the appropriate window with consistent daily logging and your target metrics have not moved in any meaningful direction — not even a small trend, not even one secondary metric — you have a null result. That is a legitimate outcome. It means this compound, at this dose, does not appear to produce measurable effects for you.
What counts as "no measurable improvement"? Less than 5% change in your primary objective metric over the active phase, with no consistent directional trend in your subjective ratings. If you are unsure, look at your baseline average and your active phase average side by side. If they are within noise range of each other, that is a null result.
Trigger 2: Side Effects That Outweigh Benefits
Side effects are data. They belong in your tracking log just as much as HRV and sleep scores. When you document them systematically, the cost-benefit picture becomes clear.
Common side effects worth tracking explicitly:
- GI discomfort (nausea, loose stools, bloating)
- Sleep disruption (difficulty falling asleep, vivid dreams, early waking)
- Mood changes (irritability, anxiety, emotional flatness)
- Headaches or brain fog
- Hormonal signals (changes in libido, energy patterns, recovery)
If your tracked side effects are consistently present and your benefit metrics have not moved meaningfully, the calculation is straightforward. Even if you feel a small benefit, weigh it against the cost in comfort and quality of life.
Trigger 3: Goals Have Changed
Supplements address specific targets. A supplement you started to improve sleep quality during a high-stress work period may not have a clear role in your stack once that stress period is over and your sleep has normalized for other reasons.
Review your stack periodically against your current goals. If a supplement no longer maps to an active goal, it is a candidate for elimination — even if it worked well at the time.
Trigger 4: You Cannot Isolate Its Contribution
If you have been taking a supplement as part of a multi-compound stack for over a year and have never run an isolation test, you do not actually know whether it is doing anything. That is not a reason to stop it immediately, but it is a reason to schedule an isolation test. The result of that test determines whether you continue.
Rapid Isolation Check: Remove the supplement for 2–3 weeks and track your metrics. If nothing meaningfully changes, you have just discovered you have been paying for something that was not contributing.
The Sunk Cost Trap
The most common reason people continue ineffective supplements is sunk cost: they already bought a three-month supply, so they feel obligated to finish it.
Sunk costs are economically irrational. The money is already spent. The only question that matters for the decision is: "Does continuing this supplement produce value going forward?"
If your data says no, stopping at day 20 of a 90-day bottle is the rational move. The alternative is 70 more days of consuming something that is not working, at the cost of stack clarity and ongoing daily pill burden.
When to Retest Instead of Permanently Stopping
Stopping a supplement is not always permanent. There are scenarios where a retest makes sense later:
- You ran the initial experiment too short (under the minimum duration) and concluded too early
- Your baseline health status has changed significantly since the original experiment
- A new form or delivery method of the same compound became available
- You want to run a proper ABA design after previously running only a single-phase test
When you do retest, treat it as a fresh experiment — new baseline period, new active phase, same tracking discipline. Do not rely on memory of how you felt years ago.
Be the first to try Prova
We're building an app to track whether supplement optimization actually works. Join the waitlist.
Keeping a Supplement Decision Log
Every experiment result — continue, stop, or retest — belongs in a decision log. Over time, this log becomes one of your most valuable health resources. It is a record of what you tried, what the data showed, and what you decided.
A minimal decision log entry looks like this:
Supplement: Ashwagandha 600mg Trial period: 6 weeks (March 1 – April 12) Primary metric: Morning HRV Result: +7% average HRV during active phase vs. baseline, sustained across full 6 weeks Secondary signals: Sleep quality score +5%, subjective stress rating down ~1.5 points Side effects: None noted Decision: Continue. Retest in 6 months via washout to confirm continued contribution.
Supplement: B-complex (standard dose) Trial period: 4 weeks Primary metric: Afternoon energy (1–10 subjective) Result: No change. Baseline avg 6.1, active phase avg 6.2. Side effects: Urine discoloration (expected), no other signals Decision: Stop. Null result after adequate trial.
This log does not need to be elaborate. It just needs to exist.